Novartis will be releasing its Q1 earnings figures on April 23rd. The experts predict that Novartis AG’s data will reflect the earnings of $1.10 per share along with overall profit of $12.90 million for the recent quarter. Novartis AG is a healthcare giant. The company has many research, development, marketing and manufacturing corporations working in healthcare sectors under its wings. Novartis has stakes in eye care, generic drugs, over the counter products, preventive vaccines, medicines and diagnostic tools.
Last time company released its earnings figure on January 27. The Thomson Reuters predicted the estimate of $1.21 earnings per share that time. The company data also matched the similar prediction. Last time it also reported the revenue of $14.63 billion, bit low according to the prediction of $14.68 billion. Per share earnings were $1.20 last year in the same quarter. Novartis AG’s was 4.7 percent down in terms of quarterly profit. The experts point out that the company will be giving $5.54 EPS by the end of next fiscal year following $5.16 EPS this financial year.
On New York Stock Exchange, the company was trading at $103.45, down by 0.60 percent. The overall trading number of shares was 1,359,960. The 50 day moving average for the Novartis is around $100 as compared to 200 day moving average of $96. This shows extreme fluctuations in its trading values. The market cap of the company is $248.14 billion along with price to earnings ratio of 25.05. Zacks, market analysis agency has downgraded the company’s stock to sell.